<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2021.07.20.21260565</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Sports Medicine</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The devil is in the details: Reporting and transparent research practices in sports medicine and orthopedic clinical trials</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4830-309X</contrib-id>
<name><surname>Schulz</surname><given-names>Robert</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4285-5253</contrib-id>
<name><surname>Langen</surname><given-names>Georg</given-names></name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4916-1206</contrib-id>
<name><surname>Prill</surname><given-names>Robert</given-names></name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6947-4517</contrib-id>
<name><surname>Cassel</surname><given-names>Michael</given-names></name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7490-2600</contrib-id>
<name><surname>Weissgerber</surname><given-names>Tracey</given-names></name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Berlin Institute of Health at Charit&#x00E9; Universit&#x00E4;tsmedizin, QUEST Center for Transforming Biomedical Research</institution>, Berlin, <country>Germany</country></aff>
<aff id="a2"><label>2</label><institution>University of Potsdam, Department of Sport and Health Sciences</institution>, Potsdam, <country>Germany</country></aff>
<aff id="a3"><label>3</label><institution>Institute for Applied Training Science</institution>, Leipzig, <country>Germany</country></aff>
<aff id="a4"><label>4</label><institution>Brandenburg Medical School Theodor Fontane, Department of Orthopedics and Traumatology</institution>, Brandenburg, <country>Germany</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Corresponding author:</bold> Tracey Weissgerber, PhD, Berlin Institute of Health at Charit&#x00E9; (BIH), BIH QUEST Center for Transforming Biomedical Research Anna-Louisa-Karsch-Str. 2, 10178 Berlin <email>tracey.weissgerber@charite.de</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2021</year>
</pub-date>
<elocation-id>2021.07.20.21260565</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>7</month>
<year>2021</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>7</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>7</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution-NoDerivs 4.0 International), CC BY-ND 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nd/4.0/">http://creativecommons.org/licenses/by-nd/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="21260565.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<sec>
<title>Introduction</title>
<p>While transparent reporting of clinical trials is essential to assess the risk of bias and translate research findings into clinical practice, earlier studies have shown that deficiencies are common. This study examined current clinical trial reporting and transparent research practices in sports medicine and orthopedics.</p></sec>
<sec>
<title>Methods</title>
<p>The sample included clinical trials published in the top 25&#x0025; of sports medicine and orthopedics journals over eight months. Two independent reviewers assessed pre-registration, open data and criteria related to scientific rigor, the study sample, and data analysis.</p></sec>
<sec>
<title>Results</title>
<p>The sample included 163 clinical trials from 27 journals. While the majority of trials mentioned rigor criteria, essential details were often missing. Sixty percent (confidence interval [CI] 53-68&#x0025;) of trials reported sample size calculations, but only 32&#x0025; (CI 25-39&#x0025;) justified the expected effect size. Few trials indicated the blinding status of all main stakeholders (4&#x0025;; CI 1-7&#x0025;). Only 18&#x0025; (CI 12-24&#x0025;) included information on randomization type, method, and concealed allocation. Most trials reported participants&#x2019; sex/gender (95&#x0025;; CI 92-98&#x0025;) and information on inclusion and exclusion criteria (78&#x0025;; CI 72-84&#x0025;). Only 20&#x0025; (CI 14-26&#x0025;) of trials were pre-registered. No trials deposited data in open repositories.</p></sec>
<sec>
<title>Conclusions</title>
<p>These results will aid the sports medicine and orthopedics community in developing tailored interventions to improve reporting. While authors typically mention blinding, randomization and other factors, essential details are often missing. Greater acceptance of open science practices, like pre-registration and open data, is needed. These practices have been widely encouraged, we discuss systemic interventions that may improve clinical trial reporting.</p></sec>
<sec>
<title>Registration</title>
<p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17605/OSF.IO/9648H">https://doi.org/10.17605/OSF.IO/9648H</ext-link></p></sec>
</abstract>
<counts>
<page-count count="35"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>This study received no external funding.</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>Not applicable, because this article does not contain any studies with human or animal subjects.</p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The overarching goal of medical research is to improve healthcare for patients, which requires the biomedical community to translate study outcomes into clinical practice (<xref ref-type="bibr" rid="c1">1</xref>). Clinical trials are central to this process, as properly conducted trials reduce the risk of bias and increase the likelihood that results about new treatments will be trustworthy, reproducible and generalizable (<xref ref-type="bibr" rid="c2">2</xref>,<xref ref-type="bibr" rid="c3">3</xref>). Clinical trials must be properly designed, conducted, and reported (<xref ref-type="bibr" rid="c4">4</xref>) to facilitate translation. Poorly designed and conducted trials may not be trustworthy or reproducible. This undermines public trust in biomedical research and raises concerns about whether the trial costs and patient risks were justified (<xref ref-type="bibr" rid="c5">5</xref>,<xref ref-type="bibr" rid="c6">6</xref>). Poor reporting makes it difficult to distinguish between trials with and without a high risk of bias.</p>
<p>To improve clinical trial reporting, the Consolidated Standards of Reporting Trials (CONSORT) guidelines (<xref ref-type="bibr" rid="c7">7</xref>,<xref ref-type="bibr" rid="c8">8</xref>) have been recommended by the ICMJE and widely disseminated by the EQUATOR network (<xref ref-type="bibr" rid="c9">9</xref>,<xref ref-type="bibr" rid="c10">10</xref>). While reporting has improved over time, major deficiencies that can impair translation are still common (<xref ref-type="bibr" rid="c11">11</xref>,<xref ref-type="bibr" rid="c12">12</xref>). Details needed to assess the risk of bias were missing from many published trials. More than half of all trials failed to address allocation concealment, and almost one third of studies did not address blinding of participants and personnel (<xref ref-type="bibr" rid="c12">12</xref>). Similarly, among randomized controlled trials published in the top five orthopedics journals, 60&#x0025; failed to address the blinding status of the participants and 58&#x0025; did not specify the number of participants included in the final analysis (<xref ref-type="bibr" rid="c13">13</xref>).</p>
<p>Orthopedics and sports medicine researchers have joined efforts to improve study design and reporting. Newly formed societies (<xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c15">15</xref>) and editorial series (<xref ref-type="bibr" rid="c16">16</xref>) focus on improving research quality in sports medicine and orthopedics. These efforts are urgently needed, as only 1&#x0025; of studies in high-impact orthopedic journals reported all ten criteria needed for risk of bias assessment (<xref ref-type="bibr" rid="c13">13</xref>). In 42&#x0025; of papers, risk of bias could not be assessed due to incomplete reporting (<xref ref-type="bibr" rid="c13">13</xref>). Incomplete reporting of exercise interventions (<xref ref-type="bibr" rid="c17">17</xref>) makes it impossible to implement interventions in clinical practice or to assess the appropriateness of the control intervention (<xref ref-type="bibr" rid="c18">18</xref>).</p>
<p>In sports medicine related fields, meta-researchers suggested that scientists may be using questionable research practices (<xref rid="tbl1" ref-type="table">Table 1</xref>) after observing overinflated effect sizes (<xref ref-type="bibr" rid="c19">19</xref>) and an unreasonably high number of papers that support the study hypothesis (<xref ref-type="bibr" rid="c20">20</xref>). Comprehensive reporting may prevent these biases or make them easier to detect. However, earlier studies have shown that reporting deficiencies are still common in orthopedics (<xref ref-type="bibr" rid="c13">13</xref>) and general medical journals (<xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c21">21</xref>).</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><p>Terminology and concepts</p></caption>
<graphic xlink:href="21260565v1_tbl1.tif"/>
</table-wrap>
<p>Therefore, this meta-research study examined reporting among clinical trials published in the top 25&#x0025; of sports medicine and orthopedics journals. Our objective was to assess the prevalence of reporting for selected criteria, including pre-registration, open data and reporting of randomization, blinding, sample size calculations, data analysis and the flow of participants through the study. Meta-research data on clinical trial design, conduct and reporting will help researchers in sports medicine to implement targeted measures to improve trial design and reporting.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2a">
<title>Protocol Pre-registration</title>
<p>The study was pre-registered on the Open Science Framework (RRID:SCR_003238) at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17605/OSF.IO/9648H">https://doi.org/10.17605/OSF.IO/9648H</ext-link>. Additional details regarding sample selection and screening, data abstraction, and sample size calculation can be found in the supplemental materials.</p>
</sec>
<sec id="s2b">
<title>Sample selection and screening</title>
<p>We systematically examined clinical trials published in the top 25&#x0025; of orthopedics and sports medicine journals over eight months. This sampling strategy provides a broad overview of practices in the field while including high-impact journals, which have the potential to drive change. Journals in the orthopedics and sports medicine category were selected based on the Scimago Journal Rank indicator (<xref ref-type="bibr" rid="c34">34</xref>) (supplementary methods). The top 25&#x0025; of journals (n=65) were entered into the PubMed search with article type (clinical trial) and publication date (2019/12:2020/08) filters. The search was run on September 16, 2020. All articles (n=175 from 27 journals) were uploaded into Rayyan (RRID:SCR_017584; 35) for screening. Two reviewers (RS, GL) screened titles and abstracts to exclude articles that were obviously not clinical trials, as defined by the ICMJE. The ICMJE defines a clinical trial as any research project that &#x201C;prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the relationship between a health-related intervention and a health outcome&#x201D;(<xref ref-type="bibr" rid="c9">9</xref>). Two independent reviewers (RS, GL, RP) then performed full-text screening. All papers meeting the ICMJE clinical trial definition were included, whereas articles that did not meet the definition were excluded. Studies looking at both health-related and non-health-related outcomes were included but data abstraction focused on health-related outcomes only. Disagreements were resolved by consensus.</p>
</sec>
<sec id="s2c">
<title>Data abstraction</title>
<p>Two independent assessors (RS, GL, RP) reviewed each article and its supplemental files to evaluate the reporting of pre-specified criteria and extracted data using preformatted Excel spreadsheets. <xref rid="tbl2" ref-type="table">Table 2</xref> presents the main criteria that were abstracted and a reason for their selection. The transparency and rigor criteria are based on CONSORT criteria for methods and results reporting (<xref ref-type="bibr" rid="c7">7</xref>,<xref ref-type="bibr" rid="c8">8</xref>). We also abstracted additional open science criteria, focusing on open access and open data (<xref ref-type="bibr" rid="c36">36</xref>,<xref ref-type="bibr" rid="c37">37</xref>). The abstraction protocol was deposited on the Open Science Framework (RRID:SCR_003238) at <ext-link ext-link-type="uri" xlink:href="https://osf.io/q8b46/">https://osf.io/q8b46/</ext-link>.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><p>Criteria for reporting and transparent research practices. The table shows specific questions used to assess each outcome criteria and provides a brief justification for why each criteria was selected.</p></caption>
<graphic xlink:href="21260565v1_tbl2.tif"/>
<graphic xlink:href="21260565v1_tbl2a.tif"/>
</table-wrap>
</sec>
<sec id="s2d">
<title>Protocol Deviations</title>
<p>For trials with exercise interventions, we assessed the frequency, intensity, and volume of exercise for experimental and control interventions. The protocol was modified if the control intervention did not involve exercise. Control interventions were rated as fully reported if the frequency, the content, and the duration was described. Control groups that received no intervention (e.g. wait-and-see) were rated as fully reported if the activity status or number of other treatments were monitored.</p>
<p>Trial registration statement assessments were amended to determine whether trials were registered prospectively or retrospectively. Two abstractors (RS, MP) assessed each trial registration. Trials were considered pre-registered if their registration was completed before the first participant was enrolled. Otherwise, the trial was classified as retrospectively registered. If the primary outcome was changed after the study began, the trial was classified as retrospectively registered.</p>
</sec>
<sec id="s2e">
<title>Statistical Analysis</title>
<p>This exploratory study assessed the prevalence of reporting for selected criteria in sports medicine and orthopedics clinical trials. Results are presented as the percentage of trials reporting each outcome measure, with a 95&#x0025; confidence interval.</p>
<p>Odds ratios and their 95&#x0025; confidence intervals were calculated to examine the relationship between the completeness of reporting and pre-registration, the use of flow charts, or the presence of sample size calculations and the completeness of reporting. Odds ratios were interpreted as unclear if the confidence interval included 1. These analyses were not pre-registered.</p>
</sec>
<sec id="s2f">
<title>Sample Size Calculation</title>
<p>This exploratory study does not require formal sample size calculations. However, we adhered to conventional sample size recommendations for exploratory designs and performed a precision-based sample size calculation to obtain rough estimates of relevant sample sizes (supplemental methods). Depending on different assumptions, a required sample size of 124 to 203 trials was estimated.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<p>175 articles were screened, and 168 articles were reviewed from 27 sports medicine and orthopedics journals (Figure S1, Table S1). Eleven articles were excluded because they did not meet the ICMJE clinical trial criteria. One extended conference abstract was excluded because it was not a full-length research article. Analyses included the remaining 163 papers.</p>
<sec id="s3a">
<title>Rigor and Sample Criteria</title>
<sec id="s3a1">
<title>Sample size calculations</title>
<p>In trials not reporting a priori sample size calculation (<xref rid="fig1" ref-type="fig">Figure 1</xref>), 2&#x0025; (CI 0-5&#x0025;; n=4) reported that no sample size calculation was performed because the study was an exploratory pilot study. Among trials reporting sample size calculations (n=98), 53&#x0025; (CI 43-63&#x0025;; n=52) included a justification for the expected effect size. The remaining trials either presented no justification (39&#x0025;; CI 23-42; n=32) or used arbitrary effect size thresholds (14&#x0025;; CI 7-21&#x0025;; n=14). Almost all sample size calculations were based on statistical power (93&#x0025;; CI 88-98&#x0025;; n=96). Two sample size calculations were based on precision (2&#x0025;; CI 0-5&#x0025;). No calculations were based on Bayes methods.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1</label>
<caption><p>Reporting prevalence for rigor and sample criteria. This plot displays the percentage of trials that addressed each criteria. For information on the actual randomization or blinding status, please refer to the text. The different colored data points are for better visual differentiation of each subcategory.</p></caption>
<graphic xlink:href="21260565v1_fig1.tif"/>
</fig>
</sec>
<sec id="s3a2">
<title>Randomization and allocation concealment</title>
<p>In trials not addressing randomization (<xref rid="fig1" ref-type="fig">Figure 1</xref>), two trials (1&#x0025;; CI 0-3&#x0025;) were not randomized, and five trials did not mention randomization (3&#x0025;; CI 0-6&#x0025;).</p>
<p>Eight percent (CI 4-12&#x0025;; n=13) of trials provided complete information on the allocation concealment procedure (defined as reporting who generated the randomization sequence, and who enrolled participants and assigned them to interventions). Some of this information was available 23&#x0025; (CI 16-29&#x0025;; n=37) of trials, and 69&#x0025; (CI 62-76&#x0025;; n=113) did not report any information. Few studies reported at least some information on all three factors needed to assess randomization and allocation concealment (randomization type, method, and allocation concealment; 18&#x0025;; CI 12-24&#x0025;; n=30).</p>
</sec>
<sec id="s3a3">
<title>Blinding</title>
<p>Two-thirds of trials addressed blinding (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Among trials that addressed blinding (<xref rid="fig1" ref-type="fig">Figure 1</xref>), 81&#x0025; (CI 73-88&#x0025;; n=84) used blinding, while 19&#x0025; (CI 12-27&#x0025;; n=20) were not blinded. Only 4&#x0025; (CI 1-7&#x0025;; n=7) of all trials addressed the blinding status of all four stakeholder groups (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Trials were most likely to address the blinding status of the outcome assessors and the participants. The blinding status of data analysts is typically unreported.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2</label>
<caption><p>The blinding status across the main different stakeholder groups across all clinical trials (n=163)</p></caption>
<graphic xlink:href="21260565v1_fig2.tif"/>
</fig>
</sec>
<sec id="s3a4">
<title>Sample-related Criteria</title>
<p>Approximately three-quarters of trials reported the inclusion and exclusion criteria and provided complete information on the number of participants at enrollment, after enrollment, and included in data analysis (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Fewer trials used a flow chart to illustrate the number of included and excluded participants at each stage. Among trials that did not report the reasons for all exclusions after enrollment (<xref rid="fig1" ref-type="fig">Figure 1</xref>), 17&#x0025; (CI 11-22&#x0025;; n=24/90) reported the reasons for some exclusions and 33&#x0025; (CI 26-41&#x0025;; n=41/90) did not report any information.</p>
<p>In trials that stated participants&#x2019; sex or gender (<xref rid="fig1" ref-type="fig">Figure 1</xref>), a median of 51&#x0025; (interquartile range (IQR) 27-71&#x0025;) of participants were women in the group with the highest proportion of women, vs. 49&#x0025; (IQR 22-66&#x0025;) in the group with the lowest proportion of women.</p>
</sec>
<sec id="s3a5">
<title>Intervention Criteria</title>
<p>The most frequent intervention type was exercise (44&#x0025;; CI 37-52&#x0025;; n=72), followed by surgery (26&#x0025;; 19-32&#x0025;; n=42). Diet (6&#x0025;; CI 2-9&#x0025;; n=9), physical therapy (5&#x0025;; CI 2-8&#x0025;; n=8), pharmacological interventions (4&#x0025;;CI 0-2&#x0025;; n=7) and manual therapy (1&#x0025;; CI 0-2&#x0025;; n=1) were uncommon. Fifteen percent (CI 9-20&#x0025; n=24) of studies used other interventions.</p>
<p>We next examined reporting of details needed to assess or implement exercise interventions.Sixty-two percent (CI 50-73&#x0025;; n=42) of trials with exercise interventions monitored adherence or compliance, one trial (1&#x0025;; CI 0-4&#x0025;) reported that adherence was not monitored, and 37&#x0025; (CI 25-48&#x0025;; n=25) of trials did not mention intervention adherence or compliance. All trials reported at least some information about the experimental exercise intervention, and most trials provided complete information (<xref rid="tbl2" ref-type="table">Table 2</xref>) (83&#x0025;; CI 75-92&#x0025;; n=60). Fewer trials reported complete information for the control interventions (63&#x0025;; CI 51-74&#x0025;; n=45). Five trials did not provide any information about the control intervention (7&#x0025;; CI 1-13&#x0025;).</p>
</sec>
</sec>
<sec id="s3b">
<title>Data analysis and Transparency Criteria</title>
<sec id="s3b1">
<title>Hypotheses and outcome measures</title>
<p>Nearly half of the articles specified a primary outcome and almost two-thirds of articles presented a hypothesis (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Among clinical trials that reported a hypothesis (<xref rid="fig3" ref-type="fig">Figure 3</xref>), 61&#x0025; (CI 53-68&#x0025;; n=62) supported the main hypothesis, while 39&#x0025; of trials (CI 32-47; n=40) did not support the main hypothesis.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3</label>
<caption><p>Reporting prevalence for data analysis and transparency criteria. This plot displays the percentage of trials that addressed each criteria. Abbreviations: NHST, null hypothesis statistical testing; ES, effect size</p></caption>
<graphic xlink:href="21260565v1_fig3.tif"/>
</fig>
</sec>
<sec id="s3b2">
<title>Statistical Reporting</title>
<p>Almost all studies used NHST (<xref rid="fig3" ref-type="fig">Figure 3</xref>). While most trials reported exact p-values, few reported test statistics and degrees of freedom. Approximately half of the trials reported standardized effect sizes but only 21&#x0025; included the precision of the effect size estimates. One study reported Bayesian statistics (1&#x0025;; CI 0-2&#x0025;).</p>
</sec>
<sec id="s3b3">
<title>Data visualization</title>
<p>Bar graphs were used to display continuous data in 21&#x0025; (CI 15-21&#x0025;; n=34) of trials. These graphs should be replaced with more informative graphics (e.g. dot plots, box plots or violin plots) that show the data distribution(<xref ref-type="bibr" rid="c49">49</xref>,<xref ref-type="bibr" rid="c50">50</xref>).</p>
</sec>
<sec id="s3b4">
<title>Transparency</title>
<p>Most of the studies with registration statements (<xref rid="fig3" ref-type="fig">Figure 3</xref>) were registered in <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link> (n=52), followed by the Australian New Zealand Clinical Trials Registry (n=9), International Standard Randomized Controlled Trial Number Register (n=4), and other regional clinical trials registries (n=9). Less than half of the registered trials, and 20&#x0025; of all trials, were pre-registered. The remaining trials with registration statements were registered retrospectively (58&#x0025;; CI 48-69&#x0025;; n=49/84). This included six prospectively registered trials where the primary outcome was changed after data collection started. Two studies with registration statements did not provide sufficient information to determine whether the study was registered prospectively or retrospectively (2&#x0025;; CI 0-6&#x0025;; n=2/84).</p>
<p>Data availability statements were uncommon (<xref rid="fig3" ref-type="fig">Figure 3</xref>). No trial with a data availability statement deposited data publically in an open repository. Twenty-one percent of trials with data availability statements (15-27&#x0025;; n=4) noted that data were not publicly available, whereas 74&#x0025; (67-80&#x0025;; n=15) stated that data were available upon request. One study (5&#x0025;; CI 2-9&#x0025;) reported that all data were available in the main text and its supplements, however, raw data was not available in either location.</p>
</sec>
</sec>
<sec id="s3c">
<title>Exploratory analyses</title>
<sec id="s3c1">
<title>Pre-registration and reporting</title>
<p>Compared to unregistered or retrospectively registered studies, pre-registered studies were more likely to report complete information for randomization (type and method) and allocation concealment (OR 4.3; CI 1.9-10.0), whether all stakeholders were blinded (OR 8.6; CI 1.6-46.5), a priori sample size calculations (OR 2.5; CI 1.1-5.8), justifications for expected effect sizes used in power calculations (OR 2.5; CI 1.1-5.8), and specifying the primary outcome measure (OR 3.3; CI 1.5-7.1). The odds of reporting (OR 1.0; CI 0.48-2.1) or rejecting (OR 1.0; CI 0.42-2.6) the study hypothesis were not clearly different between unregistered and pre-registered studies.</p>
</sec>
<sec id="s3c2">
<title>Sample size calculations and reporting</title>
<p>The odds of rejecting the main hypothesis in trials with a priori sample calculations were unclear (OR 1.3; CI 0.6-2.8). Trials that provided justifications for the expected effect size were more likely to reject the study hypothesis (OR 2.5; CI 1.2-5.2).</p>
</sec>
<sec id="s3c3">
<title>Flow charts and reporting</title>
<p>The odds of reporting all reasons for dropouts (OR 4.6; CI 2.3-9.3) and explicitly reporting the number of participants in each group that were included in the data analysis (OR 163.3; CI 21.4-1248.5) were higher among studies that used flow charts to track participant flow, compared to those that did not.</p>
</sec>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>Sports medicine and orthopedics researchers have recently emphasized rigorous study design and reporting to make research easier to understand, interpret, and translate into clinical practice (<xref ref-type="bibr" rid="c16">16</xref>). Calls for more transparent reporting in orthopedics and sports medicine (<xref ref-type="bibr" rid="c19">19</xref>,<xref ref-type="bibr" rid="c26">26</xref>,<xref ref-type="bibr" rid="c59">59</xref>) followed older studies suggesting that poor clinical trial reporting limits readers ability to assess study quality and risk of bias (<xref ref-type="bibr" rid="c13">13</xref>,<xref ref-type="bibr" rid="c60">60</xref>,<xref ref-type="bibr" rid="c61">61</xref>). Our study shows that while most studies include a general statement about rigor criteria, like blinding or randomization, these statements lack essential details needed to assess the risk of bias. The majority of trials report criteria related to the study sample, such as the sex of participants, inclusion and exlusion criteria, or the number of participants finally included in the analysis. Only 20&#x0025; of studies were pre-registered. No study shared data in open repositories.</p>
<sec id="s4a">
<title>Opportunities to improve reporting</title>
<p>These results highlight two main opportunities to improve transparency and reproducibility in sports medicine and orthopedics clinical trials; improving reporting for essential details of the main CONSORT elements and increasing uptake of open science practices.</p>
<p>First, our results indicate that most authors are aware that they need to address factors like blinding, randomization and sample size calculations; however, few provide the essential details required to evaluate the trial and interpret the results. Almost all trials addressed blinding, for example, but only 4&#x0025; reported the blinding status of all main stakeholders. Educational efforts should emphasize the difference between informative and uninformative reporting (see example in <xref rid="fig4" ref-type="fig">Figure 4</xref>). CONSORT writing templates may also help (<xref ref-type="bibr" rid="c60">60</xref>). Target criteria should include the blinding status of all main stakeholders, randomization type and method, how and by whom concealed allocation was performed, and effect size justifications in sample size calculations.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4</label>
<caption><p>A priori sample size calculations are essential for generating meaningful results with clinical trials</p></caption>
<graphic xlink:href="21260565v1_fig4.tif"/>
</fig>
<p>Second, interventions are needed to increase pre-registration and data sharing. Although the ICJME has required clinical trial pre-registration since 2005 (<xref ref-type="bibr" rid="c61">61</xref>), only one-fifth of trials were pre-registered. Pre-registered studies had higher odds of reporting several rigor criteria, potentially suggesting that authors who preregister may be more aware of reporting guidelines. Our results are consistent with previous findings (<xref ref-type="bibr" rid="c62">62</xref>) that trial registrations were among the least reported CONSORT items in sports medicine. Sports medicine researchers have already noted that pre-registration and registered reports can prevent questionable research practice (<xref ref-type="bibr" rid="c26">26</xref>) (<xref rid="tbl1" ref-type="table">Table 1</xref>) or make them easier to detect (<xref ref-type="bibr" rid="c63">63</xref>).</p>
<p>Data were not shared in public repositories, suggesting that this topic requires special attention. The benefits of data sharing for authors include more citations (<xref ref-type="bibr" rid="c64">64</xref>,<xref ref-type="bibr" rid="c65">65</xref>), and increased opportunities to collaborate with researchers who want to perform secondary analyses (<xref ref-type="bibr" rid="c66">66</xref>). Recent materials have addressed many common concerns about sharing patient data, including data privacy and confidentiality (<xref ref-type="bibr" rid="c67">67</xref>&#x2013;<xref ref-type="bibr" rid="c69">69</xref>). Regulations vary by country and institution. Some institutions have designated support staff for data sharing. Researchers should contact their institutions&#x2019; data privacy, statistics, or ethics offices to identify local experts. Seventy-four percent of trials with data availability statements noted that data were available on request. This is problematic, as such data are often unavailable and the odds of obtaining data decline precipitously with time since publication (<xref ref-type="bibr" rid="c70">70</xref>).</p>
<p>Interestingly, our exploratory analysis revealed that the odds of rejecting the study hypothesis were 2.5 (CI 1.2-5.2) times higher in trials that provided a justification for the expected effect size in sample size calculations. This might indicate overinflated effect sizes, as trials that based their sample size calculation on effect sizes published in earlier studies more often failed to find a similar sized effect. Inflated effect sizes were also observed in the psychological science reproducibility project, where replicated effects were generally smaller than those in the initial studies (<xref ref-type="bibr" rid="c71">71</xref>).</p>
<p>Authors should also be encouraged to report the data analysis transparently. Our study shows that reporting of test statistics and degrees of freedom yields much potential for improvement, as well as reporting of standardized effect sizes and their precision. Focusing on the magnitude and precision of differences, instead making decisions based on p-value thresholds, reduces the likelihood of spurious findings (<xref ref-type="bibr" rid="c72">72</xref>,<xref ref-type="bibr" rid="c73">73</xref>). Twenty-five to 38&#x0025; of medical articles (<xref ref-type="bibr" rid="c74">74</xref>), and up to 50&#x0025; in psychology papers (<xref ref-type="bibr" rid="c47">47</xref>), contain p-values that don&#x2019;t match the reported test-statistic and degrees of freedom. These inaccurate p-values may alter study conclusions in 13&#x0025; of psychology papers (<xref ref-type="bibr" rid="c47">47</xref>). Our study shows that these assessments are impossible in sports medicine and orthopedics clinical trials, as test statistics and degrees of freedom are rarely reported.</p>
<p>Reporting of criteria related to the study sample and to exercise interventions highlighted some positive points. Whereas Costello et al. (<xref ref-type="bibr" rid="c75">75</xref>) observed that less than 40&#x0025; of sports and exercise study participants were females, indicating sex bias, our study, on average, shows an even distribution of sex/gender. Similarly the number of participants included in the analysis was reported in 75&#x0025; of trials in the present study, compared to 42&#x0025; of randomized controlled trials in orthopedic journals (<xref ref-type="bibr" rid="c13">13</xref>). The introduction of flow charts to display the participant flow in CONSORT 2010 may improve reporting for sample related criteria, as trials which included flow charts were more likely to report the number of participants included in the analysis and reasons for all exclusions. While the majority of studies reported key details of exercise interventions, reporting was less comprehensive for the control intervention and for intervention adherence or compliance.</p>
</sec>
<sec id="s4b">
<title>Options for systemic interventions to improve reporting</title>
<p>Ongoing reporting deficiencies in clinical trials highlight the need for systemic interventions to improve reporting. The 2010 CONSORT guideline has been endorsed by more than 50&#x0025; of the core medical journals and the ICMJE (<xref ref-type="bibr" rid="c76">76</xref>). Persistent reporting deficiencies (<xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c21">21</xref>) indicate that endorsement without enforcement is insufficient (<xref ref-type="bibr" rid="c77">77</xref>,<xref ref-type="bibr" rid="c78">78</xref>), and engaging individuals, journals, funders, and institutions is necessary to improve reporting (<xref ref-type="bibr" rid="c79">79</xref>,<xref ref-type="bibr" rid="c80">80</xref>).</p>
<p>One option to improve reporting is for journals to enforce existing guidelines and policies. All journals in our sample were peer reviewed; yet there were major essential details were often missing from published trials. This suggests that peer review alone is insufficient. Alternatives include rigorous manual review by trained &#x201C;trial reporting&#x201D; assessors, automated screening or a combined approach. A journal program that trained early career researchers to check for common data visualization errors was well accepted by authors and increased compliance with data presentation guidelines (<xref ref-type="bibr" rid="c81">81</xref>). Implementing similar programs, using paid staff, could improve CONSORT compliance. Alternatively, automated screening tools may efficiently flag missing information for peer reviewers (<xref ref-type="bibr" rid="c82">82</xref>,<xref ref-type="bibr" rid="c83">83</xref>). Peer review systems at several journals include an automated tool that checks statistical reporting and guideline adherence (<xref ref-type="bibr" rid="c84">84</xref>). Tools are available to screen for risk of bias (RobotReviewer;RRID:SCR_021064 (<xref ref-type="bibr" rid="c85">85</xref>)), and CONSORT methodology criteria (CONSORT-TM;RRID:SCR_021051 (<xref ref-type="bibr" rid="c86">86</xref>)). The CONSORT tool performs well for frequently reported criteria, but needs more training data for less often reported criteria (<xref ref-type="bibr" rid="c86">86</xref>). New tools may be need to be created to assess details like the specifics of allocation concealment, blinding of specific stakeholders or justifications of expected effect sizes. As 52&#x0025; of clinical trials in our sample were published in only five journals, systemic efforts to improve reporting on journal level can make a noteable difference on clinical trial reporting in the field.</p>
<p>A second option is automated screening of sports medicine and orthopedics preprints. Preprints, which are posted on public servers such as medRxiv and sportRxiv prior to peer review, allow authors to receive feedback and improve their manuscripts before journal submission. Large-scale automated screening of bioRxiv and medRxiv preprints for rigor and transparency criteria is feasible and could raise awareness about factors affecting transparency and reproducibility (<xref ref-type="bibr" rid="c87">87</xref>). Automated screening has limitations &#x2013; the tools make mistakes and cannot always determine whether a particular item is relevant to a given study. Automated screening may complement peer review, but is not a replacement. The value of this approach will also depend on the proportion of trials that are posted as preprints.</p>
<p>Dashboards may offer a third option for improving reporting. Dashboards allow researchers to monitor changes over time and may incentivize transparent practices. Examples include dashboards on open science (<xref ref-type="bibr" rid="c88">88</xref>), and trial results reporting (<xref ref-type="bibr" rid="c89">89</xref>). In sports medicine and orthopedics, clinical trial dashboards could track transparent research practices for journals, society publishers, or all publications, and should include commonly missed items identified in this study. Researchers may need to develop new automated tools to track some criteria.</p>
<p>The scientific community has long relied on educational resources to improve reporting. On-demand resources include the CONSORT guideline use webinar by Altman (<xref ref-type="bibr" rid="c90">90</xref>), and open webinars on pre-registration, sample size justification and other topics offered by the Society for Transparency, Openness, and Replication in Kinesiology (<xref ref-type="bibr" rid="c91">91</xref>). Creating a single platform with field-relevant resources; then collaborating with large journals, publishers, and societies, may help to disseminate materials to the global orthopedics and sports medicine community.</p>
</sec>
<sec id="s4c">
<title>Limitations</title>
<p>Our CONSORT-based evaluation criteria for intervention reporting were not optimized for non-exercise or wait-and-see control interventions. While the assessments required by guidelines for intervention reporting (<xref ref-type="bibr" rid="c52">52</xref>,<xref ref-type="bibr" rid="c53">53</xref>) were beyond the scope of this study, previous studies assessed intervention reporting in detail (<xref ref-type="bibr" rid="c17">17</xref>,<xref ref-type="bibr" rid="c51">51</xref>,<xref ref-type="bibr" rid="c54">54</xref>,<xref ref-type="bibr" rid="c92">92</xref>). Larger, confirmatory studies are needed to examine relationships between different variables, as odds ratios calculated in the present study were exploratory post-hoc calculations. We examined the top 25&#x0025; sports medicine and orthopedics journals; hence our findings may not be generalizable to journals that are not indexed by PubMed, lower tier journals, or non-English journals.</p>
</sec>
</sec>
<sec id="s5">
<title>Conclusions</title>
<p>Transparent reporting of clinical trials is essential to assess the risk of bias and translate research findings into clinical practice. Despite some improvements over time, older studies and studies in other fields show persisting deficiencies in clinical trial reporting. The present study in recent sports medicine and orthopedic clinical trials shows that authors often report general information on rigor criteria but few provide the essential details to assess risk of bias required by existing guidelines. Examples include the blinding status of all main stakeholders, information on the concealed assignment, or the justification of expected effect sizes in sample size calculations. Further, transparent research practies like pre-registration or data sharing are rarely used in sports medicine and orthopedics.</p>
<p>As reporting guidelines for clinical trial reporting are long established and well accepted across medical fields, the persisting lack of detailed reporting suggests that further interventions and different approaches are needed to improve clinical trial reporting further. We present different options for future interventions might investigate rigorous peer-reviewer training, automated screening of submitted manuscripts and preprints, and field-specific dashboards to moitor reporting and transparent research practies to increase awareness and track improvements over time. Our results show which aspects of clinical trial reporting have the greatest need for improvement. Researchers can use this data to tailor future interventions to improve reporting to the needs of the sports medicine and orthopedics community.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material>
<label>Supplemental materials</label>
<media xlink:href="supplements/260565_file02.docx" />
</supplementary-material>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>All data are available on the OSF and may be accessed under the Creative Commons Attribution 4.0 International License at the following link: https://osf.io/q8b46/</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://osf.io/q8b46/">https://osf.io/q8b46/</ext-link>
</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17605/OSF.IO/Q8B46">https://doi.org/10.17605/OSF.IO/Q8B46</ext-link>
</p>
</sec>
<sec id="s6">
<title>Data availability Statement</title>
<p>All data are available on the OSF and may be accessed under the Creative Commons Attribution 4.0 International License at the following link: <ext-link ext-link-type="uri" xlink:href="https://osf.io/q8b46/">https://osf.io/q8b46/</ext-link></p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We would like to acknowledge Mia Pattillo for her valuable contributions to extracting the registration status of trials.</p>
</ack>
<sec id="s7">
<title>Competing Interests</title>
<p>All authors declare no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Emanuel</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Wendler</surname> <given-names>D</given-names></string-name>, <string-name><surname>Grady</surname> <given-names>C.</given-names></string-name> <article-title>What makes clinical research ethical?</article-title> <source>JAMA</source>. <year>2000</year>;<volume>283</volume>(<issue>20</issue>):<fpage>2701</fpage>&#x2013;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.283.20.2701</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">10819955</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Califf</surname> <given-names>RM</given-names></string-name>, <string-name><surname>DeMets</surname> <given-names>DL</given-names></string-name>. <article-title>Principles from clinical trials relevant to clinical practice: Part I</article-title>. <source>Circulation</source>. <year>2002</year>;<volume>106</volume>(<issue>8</issue>):<fpage>1015</fpage>&#x2013;<lpage>21</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.CIR.0000023260.78078</pub-id>.BB Cited in: PubMed; PMID <pub-id pub-id-type="pmid">12186809</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Gerstein</surname> <given-names>HC</given-names></string-name>, <string-name><surname>McMurray</surname> <given-names>J</given-names></string-name>, <string-name><surname>Holman</surname> <given-names>RR</given-names></string-name>. <article-title>Real-world studies no substitute for RCTs in establishing efficacy</article-title>. <source>The Lancet</source>. <year>2019</year>;<volume>393</volume>(<issue>10168</issue>):<fpage>210</fpage>&#x2013;<lpage>1</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(18)32840-X</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="other"><string-name><surname>Zarin</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Goodman</surname> <given-names>SN</given-names></string-name>, <string-name><surname>Kimmelman</surname> <given-names>J.</given-names></string-name> <article-title>Harms From Uninformative Clinical Trials</article-title>. <source>JAMA</source>. <year>2019</year>. doi:<pub-id pub-id-type="doi">10.1001/jama.2019.9892</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31343666</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Feudtner</surname> <given-names>C</given-names></string-name>, <string-name><surname>Schreiner</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lantos</surname> <given-names>JD</given-names></string-name>. <article-title>Risks (and benefits) in comparative effectiveness research trials</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>369</volume>(<issue>10</issue>):<fpage>892</fpage>&#x2013;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMp1309322</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">23964898</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>van Delden</surname> <given-names>JJM</given-names></string-name>, <string-name><surname>van der Graaf</surname> <given-names>R.</given-names></string-name> <article-title>Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans</article-title>. <source>JAMA</source>. <year>2017</year>;<volume>317</volume>(<issue>2</issue>):<fpage>135</fpage>&#x2013;<lpage>6</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2016.18977</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27923072</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Schulz</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D.</given-names></string-name> <article-title>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials</article-title>. <source>PLoS Med</source>. <year>2010</year>;<volume>7</volume>(<issue>3</issue>):<fpage>e1000251</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pmed.1000251</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">20352064</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hopewell</surname> <given-names>S</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Montori</surname> <given-names>V</given-names></string-name>, <string-name><surname>G&#x00F8;tzsche</surname> <given-names>PC</given-names></string-name>, <string-name><surname>Devereaux</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Elbourne</surname> <given-names>D</given-names></string-name>, <string-name><surname>Egger</surname> <given-names>M</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>. <article-title>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials</article-title>. <source>BMJ</source>. <year>2010</year>;<volume>340c869</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.c869</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">20332511</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="other"><collab>ICMJE</collab>. <source>Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals [Internet]</source>. <year>2020</year> [cited <date-in-citation content-type="access-date">2020 Aug 4</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ICMJE.org">http://www.ICMJE.org</ext-link>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Simera</surname> <given-names>I</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Hoey</surname> <given-names>J</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>. <article-title>Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research</article-title>. <source>BMC Med</source>. <year>2008</year>;<volume>613</volume>. doi:<pub-id pub-id-type="doi">10.1186/1741-7015-6-13</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">18558004</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Turner</surname> <given-names>L</given-names></string-name>, <string-name><surname>Shamseer</surname> <given-names>L</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>KF</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D.</given-names></string-name> <article-title>Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review</article-title>. <source>Syst Rev</source>. <year>2012</year>;<volume>160</volume>. doi:<pub-id pub-id-type="doi">10.1186/2046-4053-1-60</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">23194585</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Dechartres</surname> <given-names>A</given-names></string-name>, <string-name><surname>Trinquart</surname> <given-names>L</given-names></string-name>, <string-name><surname>Atal</surname> <given-names>I</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dickersin</surname> <given-names>K</given-names></string-name>, <string-name><surname>Boutron</surname> <given-names>I</given-names></string-name>, <string-name><surname>Perrodeau</surname> <given-names>E</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Ravaud</surname> <given-names>P.</given-names></string-name> <article-title>Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study</article-title>. <source>BMJ</source>. <year>2017</year>;<volume>357j2490</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.j2490</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28596181</pub-id>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Chess</surname> <given-names>LE</given-names></string-name>, <string-name><surname>Gagnier</surname> <given-names>J.</given-names></string-name> <article-title>Risk of bias of randomized controlled trials published in orthopaedic journals</article-title>. <source>BMC Med Res Methodol</source>. <year>2013</year>;<volume>1376</volume>. doi:<pub-id pub-id-type="doi">10.1186/1471-2288-13-76</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">23758875</pub-id>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Nielsen</surname> <given-names>RO</given-names></string-name>, <string-name><surname>Shrier</surname> <given-names>I</given-names></string-name>, <string-name><surname>Casals</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nettel-Aguirre</surname> <given-names>A</given-names></string-name>, <string-name><surname>M&#x00F8;ller</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bolling</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bittencourt</surname> <given-names>NFN</given-names></string-name>, <string-name><surname>Clarsen</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wedderkopp</surname> <given-names>N</given-names></string-name>, <string-name><surname>Soligard</surname> <given-names>T</given-names></string-name>, <string-name><surname>Timpka</surname> <given-names>T</given-names></string-name>, <string-name><surname>Emery</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bahr</surname> <given-names>R</given-names></string-name>, <string-name><surname>Jacobsson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Whiteley</surname> <given-names>R</given-names></string-name>, <string-name><surname>Dahlstrom</surname> <given-names>O</given-names></string-name>, <string-name><surname>van Dyk</surname> <given-names>N</given-names></string-name>, <string-name><surname>Pluim</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Stamatakis</surname> <given-names>E</given-names></string-name>, <string-name><surname>Palacios-Derflingher</surname> <given-names>L</given-names></string-name>, <string-name><surname>Fagerland</surname> <given-names>MW</given-names></string-name>, <string-name><surname>Khan</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Ardern</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Verhagen</surname> <given-names>E.</given-names></string-name> <article-title>Statement on methods in sport injury research from the 1st METHODS MATTER Meeting, Copenhagen, 2019</article-title>. <source>Br J Sports Med</source>. <year>2020</year>;<volume>54</volume>(<issue>15</issue>):<fpage>941</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2019-101323</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32371524</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="other"><string-name><surname>Zenko</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Steele</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mills</surname> <given-names>J.</given-names></string-name> <article-title>Communications in Kinesiology: A new open access journal from the Society for Transparency</article-title>, <source>Openness, and Replication in Kinesiology</source>; <year>2020</year>. en.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Verhagen</surname> <given-names>E</given-names></string-name>, <string-name><surname>Stovitz</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Mansournia</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Nielsen</surname> <given-names>RO</given-names></string-name>, <string-name><surname>Shrier</surname> <given-names>I.</given-names></string-name> <article-title>BJSM educational editorials: methods matter</article-title>. <source>Br J Sports Med</source>. <year>2018</year>;<volume>52</volume>(<issue>18</issue>):<fpage>1159</fpage>&#x2013;<lpage>60</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2017-097998</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28818955</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Holden</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rathleff</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Jensen</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Barton</surname> <given-names>CJ</given-names></string-name>. <article-title>How can we implement exercise therapy for patellofemoral pain if we don&#x2019;t know what was prescribed? A systematic review</article-title>. <source>Br J Sports Med</source>. <year>2018</year>;<volume>52</volume>(<issue>6</issue>):<fpage>385</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2017-097547</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">29084726</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Losina</surname> <given-names>E.</given-names></string-name> <article-title>Why past research successes do not translate to clinical reality: gaps in evidence on exercise program efficacy</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2019</year>;<volume>27</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.joca.2018.09.006</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">30248501</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Knudson</surname> <given-names>D.</given-names></string-name> <article-title>Confidence crisis of results in biomechanics research</article-title>. <source>Sports Biomech</source>. <year>2017</year>;<volume>16</volume>(<issue>4</issue>):<fpage>425</fpage>&#x2013;<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14763141.2016.1246603</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28632059</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="other"><string-name><surname>B&#x00FC;ttner</surname> <given-names>F</given-names></string-name>, <string-name><surname>Toomey</surname> <given-names>E</given-names></string-name>, <string-name><surname>McClean</surname> <given-names>S</given-names></string-name>, <string-name><surname>Roe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Delahunt</surname> <given-names>E.</given-names></string-name> <article-title>Are questionable research practices facilitating new discoveries in sport and exercise medicine? The proportion of supported hypotheses is implausibly high</article-title>. <source>Br J Sports Med</source>. <year>2020</year>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2019-101863</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32699001</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Kane</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Garrard</surname> <given-names>J.</given-names></string-name> <article-title>Reporting in randomized clinical trials improved after adoption of the CONSORT statement</article-title>. <source>J Clin Epidemiol</source>. <year>2007</year>;<volume>60</volume>(<issue>3</issue>):<fpage>241</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.06.016</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">17292017</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Banks</surname> <given-names>GC</given-names></string-name>, <string-name><surname>O&#x2019;Boyle</surname> <given-names>EH</given-names></string-name>, <string-name><surname>Pollack</surname> <given-names>JM</given-names></string-name>, <string-name><surname>White</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Batchelor</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Whelpley</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Abston</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Bennett</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Adkins</surname> <given-names>CL</given-names></string-name>. <article-title>Questions About Questionable Research Practices in the Field of Management</article-title>. <source>Journal of Management</source>. <year>2016</year>;<volume>42</volume>(<issue>1</issue>):<fpage>5</fpage>&#x2013;<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0149206315619011</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Hutton</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Williamson</surname> <given-names>PR</given-names></string-name>. <article-title>Bias in meta-analysis due to outcome variable selection within studies</article-title>. <source>Journal of the Royal Statistical Society: Series C (Applied Statistics)</source>. <year>2000</year>;<volume>49</volume>(<issue>3</issue>):<fpage>359</fpage>&#x2013;<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1467-9876.00197</pub-id></mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Bernard</surname> <given-names>R</given-names></string-name>, <string-name><surname>Weissgerber</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Bobrov</surname> <given-names>E</given-names></string-name>, <string-name><surname>Winham</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Dirnagl</surname> <given-names>U</given-names></string-name>, <string-name><surname>Riedel</surname> <given-names>N.</given-names></string-name> <article-title>fiddle: a tool to combat publication bias by getting research out of the file drawer and into the scientific community</article-title>. <source>Clin Sci (Lond)</source>. <year>2020</year>;<volume>134</volume>(<issue>20</issue>):<fpage>2729</fpage>&#x2013;<lpage>39</lpage>. doi:<pub-id pub-id-type="doi">10.1042/CS20201125</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">33111948</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Chambers</surname> <given-names>C.</given-names></string-name> <article-title>What&#x2019;s next for Registered Reports?</article-title> <source>Nature</source>. <year>2019</year>;<volume>573</volume>(<issue>7773</issue>):<fpage>187</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1038/d41586-019-02674-6</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31506624</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Caldwell</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Vigotsky</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Tenan</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Radel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mellor</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Kreutzer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lahart</surname> <given-names>IM</given-names></string-name>, <string-name><surname>Mills</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Boisgontier</surname> <given-names>MP</given-names></string-name>. <article-title>Moving Sport and Exercise Science Forward: A Call for the Adoption of More Transparent Research Practices</article-title>. <source>Sports Med</source>. <year>2020</year>;<volume>50</volume>(<issue>3</issue>):<fpage>449</fpage>&#x2013;<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40279-019-01227-1</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32020542</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Chalmers</surname> <given-names>l.</given-names></string-name> <article-title>Underreporting Research Is Scientific Misconduct</article-title>. <source>JAMA</source>. <year>1990</year>;<volume>263</volume>(<issue>10</issue>):<fpage>1405</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.1990.03440100121018</pub-id></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="other"><string-name><surname>Hopewell</surname> <given-names>S</given-names></string-name>, <string-name><surname>Loudon</surname> <given-names>K</given-names></string-name>, <string-name><surname>Clarke</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Oxman</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Dickersin</surname> <given-names>K.</given-names></string-name> <article-title>Publication bias in clinical trials due to statistical significance or direction of trial results</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2009</year>;(<issue>1</issue>):<fpage>MR000006</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.MR000006.pub3</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">19160345</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Dwan</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gamble</surname> <given-names>C</given-names></string-name>, <string-name><surname>Williamson</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Kirkham</surname> <given-names>JJ</given-names></string-name>. <article-title>Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>7</issue>):<fpage>e66844</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0066844</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">23861749</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Kirkham</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>A-W</given-names></string-name>, <string-name><surname>Gamble</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dwan</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Williamson</surname> <given-names>PR</given-names></string-name>. <article-title>Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews</article-title>. <source>BMJ</source>. <year>2018</year>;<volume>362k3802</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.k3802</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">30266736</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Nunan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Aronson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bankhead</surname> <given-names>C.</given-names></string-name> <article-title>Catalogue of bias: attrition bias</article-title>. <source>BMJ Evid Based Med</source>. <year>2018</year>;<volume>23</volume>(<issue>1</issue>):<fpage>21</fpage>&#x2013;<lpage>2</lpage>. doi:<pub-id pub-id-type="doi">10.1136/ebmed-2017-110883</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">29367321</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="other"><collab>ICMJE</collab>. <source>Recommendations &#x007C; Preparing a Manuscript for Submission to a Medical Journal: Methods - statistics [Internet]</source>. <year>2021</year> [updated 2021 Apr 14; cited <date-in-citation content-type="access-date">2021 Apr 14</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html">http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html</ext-link></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Kerr</surname> <given-names>NL</given-names></string-name>. <article-title>HARKing: hypothesizing after the results are known</article-title>. <source>Pers Soc Psychol Rev</source>. <year>1998</year>;<volume>2</volume>(<issue>3</issue>):<fpage>196</fpage>&#x2013;<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1207/s15327957pspr0203_4</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">15647155</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="other"><collab>SCImago</collab> (nd). <source>SJR &#x2014; SCImago Journal &#x0026; Country Rank [Portal] [Internet]</source>. <year>2020</year> [cited <date-in-citation content-type="access-date">2021 Feb 22</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.scimagojr.com/journalrank.php?category=2732">https://www.scimagojr.com/journalrank.php?category=2732</ext-link></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Ouzzani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hammady</surname> <given-names>H</given-names></string-name>, <string-name><surname>Fedorowicz</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Elmagarmid</surname> <given-names>A.</given-names></string-name> <article-title>Rayyan-a web and mobile app for systematic reviews</article-title>. <source>Syst Rev</source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>210</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27919275</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="other"><collab>BIH QUEST</collab>. <source>Open Science - BIH [Internet]</source>. <year>2021</year> [updated 2021 Jan 22; cited <date-in-citation content-type="access-date">2021 Jan 22</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.bihealth.org/en/research/quest-center/mission-approaches/open-science">https://www.bihealth.org/en/research/quest-center/mission-approaches/open-science</ext-link></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Nosek</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Alter</surname> <given-names>G</given-names></string-name>, <string-name><surname>Banks</surname> <given-names>GC</given-names></string-name>, <string-name><surname>Borsboom</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bowman</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Breckler</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Buck</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chambers</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Chin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Christensen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Contestabile</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dafoe</surname> <given-names>A</given-names></string-name>, <string-name><surname>Eich</surname> <given-names>E</given-names></string-name>, <string-name><surname>Freese</surname> <given-names>J</given-names></string-name>, <string-name><surname>Glennerster</surname> <given-names>R</given-names></string-name>, <string-name><surname>Goroff</surname> <given-names>D</given-names></string-name>, <string-name><surname>Green</surname> <given-names>DP</given-names></string-name>, <string-name><surname>Hesse</surname> <given-names>B</given-names></string-name>, <string-name><surname>Humphreys</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ishiyama</surname> <given-names>J</given-names></string-name>, <string-name><surname>Karlan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Kraut</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lupia</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mabry</surname> <given-names>P</given-names></string-name>, <string-name><surname>Madon</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Malhotra</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mayo-Wilson</surname> <given-names>E</given-names></string-name>, <string-name><surname>McNutt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Miguel</surname> <given-names>E</given-names></string-name>, <string-name><surname>Paluck</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Simonsohn</surname> <given-names>U</given-names></string-name>, <string-name><surname>Soderberg</surname> <given-names>C</given-names></string-name>, <string-name><surname>Spellman</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Turitto</surname> <given-names>J</given-names></string-name>, <string-name><surname>VandenBos</surname> <given-names>G</given-names></string-name>, <string-name><surname>Vazire</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wagenmakers</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yarkoni</surname> <given-names>T.</given-names></string-name> <article-title>SCIENTIFIC STANDARDS. Promoting an open research culture</article-title>. <source>Science</source>. <year>2015</year>;<volume>348</volume>(<issue>6242</issue>):<fpage>1422</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aab2374</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26113702</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Button</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Ioannidis</surname> <given-names>JPA</given-names></string-name>, <string-name><surname>Mokrysz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Nosek</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Flint</surname> <given-names>J</given-names></string-name>, <string-name><surname>Robinson</surname> <given-names>ESJ</given-names></string-name>, <string-name><surname>Munaf&#x00F2;</surname> <given-names>MR.</given-names></string-name> <article-title>Power failure: why small sample size undermines the reliability of neuroscience</article-title>. <source>Nat Rev Neurosci</source>. <year>2013</year>;<volume>14</volume>(<issue>5</issue>):<fpage>365</fpage>&#x2013;<lpage>76</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrn3475</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">23571845</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Charles</surname> <given-names>P</given-names></string-name>, <string-name><surname>Giraudeau</surname> <given-names>B</given-names></string-name>, <string-name><surname>Dechartres</surname> <given-names>A</given-names></string-name>, <string-name><surname>Baron</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ravaud</surname> <given-names>P.</given-names></string-name> <article-title>Reporting of sample size calculation in randomised controlled trials: review</article-title>. <source>BMJ</source>. <year>2009</year>;<volume>338b1732</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.b1732</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">19435763</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Abdul Latif</surname> <given-names>L</given-names></string-name>, <string-name><surname>Daud Amadera</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Pimentel</surname> <given-names>D</given-names></string-name>, <string-name><surname>Pimentel</surname> <given-names>T</given-names></string-name>, <string-name><surname>Fregni</surname> <given-names>F.</given-names></string-name> <article-title>Sample size calculation in physical medicine and rehabilitation: a systematic review of reporting, characteristics, and results in randomized controlled trials</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2011</year>;<volume>92</volume>(<issue>2</issue>):<fpage>306</fpage>&#x2013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2010.10.003</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">21272730</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Hewitt</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hahn</surname> <given-names>S</given-names></string-name>, <string-name><surname>Torgerson</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Watson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bland</surname> <given-names>JM</given-names></string-name>. <article-title>Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals</article-title>. <source>BMJ</source>. <year>2005</year>;<volume>330</volume>(<issue>7499</issue>):<fpage>1057</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.38413.576713.AE</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">15760970</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Armijo-Olivo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Saltaji</surname> <given-names>H</given-names></string-name>, <string-name><surname>da Costa</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Fuentes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ha</surname> <given-names>C</given-names></string-name>, <string-name><surname>Cummings</surname> <given-names>GG</given-names></string-name>. <article-title>What is the influence of randomisation sequence generation and allocation concealment on treatment effects of physical therapy trials? A meta-epidemiological study</article-title>. <source>BMJ Open</source>. <year>2015</year>;<volume>5</volume>(<issue>9</issue>):<fpage>e008562</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmjopen-2015-008562</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26338841</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Holman</surname> <given-names>L</given-names></string-name>, <string-name><surname>Head</surname> <given-names>ML</given-names></string-name>, <string-name><surname>Lanfear</surname> <given-names>R</given-names></string-name>, <string-name><surname>Jennions</surname> <given-names>MD</given-names></string-name>. <article-title>Evidence of Experimental Bias in the Life Sciences: Why We Need Blind Data Recording</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>7</issue>):<fpage>e1002190</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1002190</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26154287</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Haahr</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Hr&#x00F3;bjartsson</surname> <given-names>A.</given-names></string-name> <article-title>Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors</article-title>. <source>Clin Trials</source>. <year>2006</year>;<volume>3</volume>(<issue>4</issue>):<fpage>360</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1740774506069153</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">17060210</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Mathieu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Boutron</surname> <given-names>I</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Ravaud</surname> <given-names>P.</given-names></string-name> <article-title>Comparison of registered and published primary outcomes in randomized controlled trials</article-title>. <source>JAMA</source>. <year>2009</year>;<volume>302</volume>(<issue>9</issue>):<fpage>977</fpage>&#x2013;<lpage>84</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2009.1242</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">19724045</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>R</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dodd</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cornelius</surname> <given-names>V.</given-names></string-name> <article-title>Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication</article-title>. <source>JAMA Netw Open</source>. <year>2019</year>;<volume>2</volume>(<issue>7</issue>):<fpage>e197242</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.7242</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31322690</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Nuijten</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Hartgerink</surname> <given-names>CHJ</given-names></string-name>, <string-name><surname>van Assen</surname> <given-names>MALM</given-names></string-name>, <string-name><surname>Epskamp</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wicherts</surname> <given-names>JM</given-names></string-name>. <article-title>The prevalence of statistical reporting errors in psychology (1985-2013)</article-title>. <source>Behav Res Methods</source>. <year>2016</year>;<volume>48</volume>(<issue>4</issue>):<fpage>1205</fpage>&#x2013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.3758/s13428-015-0664-2</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26497820</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Lakens</surname> <given-names>D.</given-names></string-name> <article-title>Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs</article-title>. <source>Front Psychol</source>. <year>2013</year>;<volume>4863</volume>. doi:<pub-id pub-id-type="doi">10.3389/fpsyg.2013.00863</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24324449</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Weissgerber</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Milic</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Winham</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Garovic</surname> <given-names>VD</given-names></string-name>. <article-title>Beyond bar and line graphs: time for a new data presentation paradigm</article-title>. <source>PLoS Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>4</issue>):<fpage>e1002128</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1002128</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">25901488</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Weissgerber</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Winham</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Heinzen</surname> <given-names>EP</given-names></string-name>, <string-name><surname>Milin-Lazovic</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Garcia-Valencia</surname> <given-names>O</given-names></string-name>, <string-name><surname>Bukumiric</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Savic</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Garovic</surname> <given-names>VD</given-names></string-name>, <string-name><surname>Milic</surname> <given-names>NM</given-names></string-name>. <article-title>Reveal, Don&#x2019;t Conceal: Transforming Data Visualization to Improve Transparency</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>140</volume>(<issue>18</issue>):<fpage>1506</fpage>&#x2013;<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.037777</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31657957</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Slade</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Keating</surname> <given-names>JL</given-names></string-name>. <article-title>Exercise prescription: a case for standardised reporting</article-title>. <source>Br J Sports Med</source>. <year>2012</year>;<volume>46</volume>(<issue>16</issue>):<fpage>1110</fpage>&#x2013;<lpage>3</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2011-090290</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">22089077</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Hoffmann</surname> <given-names>TC</given-names></string-name>, <string-name><surname>Glasziou</surname> <given-names>PP</given-names></string-name>, <string-name><surname>Boutron</surname> <given-names>I</given-names></string-name>, <string-name><surname>Milne</surname> <given-names>R</given-names></string-name>, <string-name><surname>Perera</surname> <given-names>R</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Barbour</surname> <given-names>V</given-names></string-name>, <string-name><surname>Macdonald</surname> <given-names>H</given-names></string-name>, <string-name><surname>Johnston</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lamb</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Dixon-Woods</surname> <given-names>M</given-names></string-name>, <string-name><surname>McCulloch</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wyatt</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Chan</surname> <given-names>A-W</given-names></string-name>, <string-name><surname>Michie</surname> <given-names>S.</given-names></string-name> <article-title>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348g1687</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.g1687</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24609605</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Slade</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Dionne</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Underwood</surname> <given-names>M</given-names></string-name>, <string-name><surname>Buchbinder</surname> <given-names>R</given-names></string-name>, <string-name><surname>Beck</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bennell</surname> <given-names>K</given-names></string-name>, <string-name><surname>Brosseau</surname> <given-names>L</given-names></string-name>, <string-name><surname>Costa</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cramp</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cup</surname> <given-names>E</given-names></string-name>, <string-name><surname>Feehan</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ferreira</surname> <given-names>M</given-names></string-name>, <string-name><surname>Forbes</surname> <given-names>S</given-names></string-name>, <string-name><surname>Glasziou</surname> <given-names>P</given-names></string-name>, <string-name><surname>Habets</surname> <given-names>B</given-names></string-name>, <string-name><surname>Harris</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hay-Smith</surname> <given-names>J</given-names></string-name>, <string-name><surname>Hillier</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hinman</surname> <given-names>R</given-names></string-name>, <string-name><surname>Holland</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hondras</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kent</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lauret</surname> <given-names>G-J</given-names></string-name>, <string-name><surname>Long</surname> <given-names>A</given-names></string-name>, <string-name><surname>Maher</surname> <given-names>C</given-names></string-name>, <string-name><surname>Morso</surname> <given-names>L</given-names></string-name>, <string-name><surname>Osteras</surname> <given-names>N</given-names></string-name>, <string-name><surname>Peterson</surname> <given-names>T</given-names></string-name>, <string-name><surname>Quinlivan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rees</surname> <given-names>K</given-names></string-name>, <string-name><surname>Regnaux</surname> <given-names>J-P</given-names></string-name>, <string-name><surname>Rietberg</surname> <given-names>M</given-names></string-name>, <string-name><surname>Saunders</surname> <given-names>D</given-names></string-name>, <string-name><surname>Skoetz</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sogaard</surname> <given-names>K</given-names></string-name>, <string-name><surname>Takken</surname> <given-names>T</given-names></string-name>, <string-name><surname>van Tulder</surname> <given-names>M</given-names></string-name>, <string-name><surname>Voet</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ward</surname> <given-names>L</given-names></string-name>, <string-name><surname>White</surname> <given-names>C.</given-names></string-name> <article-title>Consensus on Exercise Reporting Template (CERT): Modified Delphi Study</article-title>. <source>Phys Ther</source>. <year>2016</year>;<volume>96</volume>(<issue>10</issue>):<fpage>1514</fpage>&#x2013;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.2522/ptj.20150668</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27149962</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><given-names>Verhagen</given-names> <surname>Ealm</surname></string-name>, <string-name><surname>Hupperets</surname> <given-names>MDW</given-names></string-name>, <string-name><surname>Finch</surname> <given-names>CF</given-names></string-name>, <string-name><surname>van Mechelen</surname> <given-names>W.</given-names></string-name> <article-title>The impact of adherence on sports injury prevention effect estimates in randomised controlled trials: looking beyond the CONSORT statement</article-title>. <source>J Sci Med Sport</source>. <year>2011</year>;<volume>14</volume>(<issue>4</issue>):<fpage>287</fpage>&#x2013;<lpage>92</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsams.2011.02.007</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">21429793</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="other"><collab>ICMJE</collab>. <source>Recommendations &#x007C; Clinical Trials [Internet]</source>. <year>2021</year> [updated 2021 Jan 19; cited <date-in-citation content-type="access-date">2021 Jan 19</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html">http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html</ext-link></mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>McKiernan</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Bourne</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>CT</given-names></string-name>, <string-name><surname>Buck</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kenall</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>J</given-names></string-name>, <string-name><surname>McDougall</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nosek</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Ram</surname> <given-names>K</given-names></string-name>, <string-name><surname>Soderberg</surname> <given-names>CK</given-names></string-name>, <string-name><surname>Spies</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Thaney</surname> <given-names>K</given-names></string-name>, <string-name><surname>Updegrove</surname> <given-names>A</given-names></string-name>, <string-name><surname>Woo</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Yarkoni</surname> <given-names>T.</given-names></string-name> <article-title>How open science helps researchers succeed</article-title>. <source>Elife</source>. <year>2016</year>;<volume>5</volume>. doi:<pub-id pub-id-type="doi">10.7554/eLife.16800</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27387362</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Vasilevsky</surname> <given-names>NA</given-names></string-name>, <string-name><surname>Minnier</surname> <given-names>J</given-names></string-name>, <string-name><surname>Haendel</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Champieux</surname> <given-names>RE</given-names></string-name>. <article-title>Reproducible and reusable research: are journal data sharing policies meeting the mark?</article-title> <source>PeerJ</source>. <year>2017</year>;<volume>5e3208</volume>. doi:<pub-id pub-id-type="doi">10.7717/peerj.3208</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28462024</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="other"><collab>European Comission</collab>. <source>Facts and Figures for open research data: Figures and case studies related to accessing and reusing the data produced in the course of scientific production. [Internet]</source>. <year>2019</year> [updated 2019 Nov 5; cited <date-in-citation content-type="access-date">2021 Apr 8</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/open-science-monitor/facts-and-figures-open-research-data_en#funderspolicies">https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/open-science-monitor/facts-and-figures-open-research-data_en#funderspolicies</ext-link></mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Halperin</surname> <given-names>I</given-names></string-name>, <string-name><surname>Vigotsky</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Foster</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pyne</surname> <given-names>DB</given-names></string-name>. <article-title>Strengthening the Practice of Exercise and Sport-Science Research</article-title>. <source>Int J Sports Physiol Perform</source>. <year>2018</year>;<volume>13</volume>(<issue>2</issue>):<fpage>127</fpage>&#x2013;<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1123/ijspp.2017-0322</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28787228</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Barnes</surname> <given-names>C</given-names></string-name>, <string-name><surname>Boutron</surname> <given-names>I</given-names></string-name>, <string-name><surname>Giraudeau</surname> <given-names>B</given-names></string-name>, <string-name><surname>Porcher</surname> <given-names>R</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Ravaud</surname> <given-names>P.</given-names></string-name> <article-title>Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial</article-title>. <source>BMC Med</source>. <year>2015</year>;<volume>13</volume>(<issue>1</issue>):<fpage>221</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12916-015-0460-y</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26370288</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Angelis</surname> <given-names>C de</given-names></string-name>, <string-name><surname>Drazen</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Frizelle</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Haug</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hoey</surname> <given-names>J</given-names></string-name>, <string-name><surname>Horton</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kotzin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Laine</surname> <given-names>C</given-names></string-name>, <string-name><surname>Marusic</surname> <given-names>A</given-names></string-name>, <string-name><given-names>Overbeke</given-names> <surname>Ajpm</surname></string-name>, <string-name><surname>Schroeder</surname> <given-names>TV</given-names></string-name>, <string-name><surname>Sox</surname> <given-names>HC</given-names></string-name>, <string-name><surname>van der Weyden</surname> <given-names>MB</given-names></string-name>. <article-title>Clinical trial registration: a statement from the International Committee of Medical Journal Editors</article-title>. <source>Ann Intern Med</source>. <year>2004</year>;<volume>141</volume>(<issue>6</issue>):<fpage>477</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.7326/0003-4819-141-6-200409210-00109</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">15355883</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Harris</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Cvetanovich</surname> <given-names>G</given-names></string-name>, <string-name><surname>Erickson</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Abrams</surname> <given-names>GD</given-names></string-name>, <string-name><surname>Chahal</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>AK</given-names></string-name>, <string-name><surname>McCormick</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Bach</surname> <given-names>BR</given-names></string-name>. <article-title>Current status of evidence-based sports medicine</article-title>. <source>Arthroscopy</source>. <year>2014</year>;<volume>30</volume>(<issue>3</issue>):<fpage>362</fpage>&#x2013;<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.arthro.2013.11.015</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24581261</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="other"><string-name><surname>Warren</surname> <given-names>M.</given-names></string-name> <article-title>First analysis of &#x2018;pre-registered&#x2019; studies shows sharp rise in null findings</article-title>. <source>Nature</source>. <year>2018</year>. doi:<pub-id pub-id-type="doi">10.1038/d41586-018-07118-1</pub-id></mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Christensen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Dafoe</surname> <given-names>A</given-names></string-name>, <string-name><surname>Miguel</surname> <given-names>E</given-names></string-name>, <string-name><surname>Moore</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Rose</surname> <given-names>AK</given-names></string-name>. <article-title>A study of the impact of data sharing on article citations using journal policies as a natural experiment</article-title>. <source>PLOS ONE</source>. <year>2019</year>;<volume>14</volume>(<issue>12</issue>):<fpage>e0225883</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0225883</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31851689</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Colavizza</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hrynaszkiewicz</surname> <given-names>I</given-names></string-name>, <string-name><surname>Staden</surname> <given-names>I</given-names></string-name>, <string-name><surname>Whitaker</surname> <given-names>K</given-names></string-name>, <string-name><surname>McGillivray</surname> <given-names>B.</given-names></string-name> <article-title>The citation advantage of linking publications to research data</article-title>. <source>PLOS ONE</source>. <year>2020</year>;<volume>15</volume>(<issue>4</issue>):<fpage>e0230416</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0230416</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32320428</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Lo</surname> <given-names>B</given-names></string-name>, <string-name><surname>DeMets</surname> <given-names>DL</given-names></string-name>. <article-title>Incentives for Clinical Trialists to Share Data</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>375</volume>(<issue>12</issue>):<fpage>1112</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMp1608351</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27653562</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Mello</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Francer</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Wilenzick</surname> <given-names>M</given-names></string-name>, <string-name><surname>Teden</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bierer</surname> <given-names>BE</given-names></string-name>, <string-name><surname>Barnes</surname> <given-names>M.</given-names></string-name> <article-title>Preparing for responsible sharing of clinical trial data</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>369</volume>(<issue>17</issue>):<fpage>1651</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMhle1309073</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24144394</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Taichman</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Sahni</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pinborg</surname> <given-names>A</given-names></string-name>, <string-name><surname>Peiperl</surname> <given-names>L</given-names></string-name>, <string-name><surname>Laine</surname> <given-names>C</given-names></string-name>, <string-name><surname>James</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>S-T</given-names></string-name>, <string-name><surname>Haileamlak</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gollogly</surname> <given-names>L</given-names></string-name>, <string-name><surname>Godlee</surname> <given-names>F</given-names></string-name>, <string-name><surname>Frizelle</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Florenzano</surname> <given-names>F</given-names></string-name>, <string-name><surname>Drazen</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Bauchner</surname> <given-names>H</given-names></string-name>, <string-name><surname>Baethge</surname> <given-names>C</given-names></string-name>, <string-name><surname>Backus</surname> <given-names>J.</given-names></string-name> <article-title>Data Sharing Statements for Clinical Trials - A Requirement of the International Committee of Medical Journal Editors</article-title>. <source>N Engl J Med</source>. <year>2017</year>;<volume>376</volume>(<issue>23</issue>):<fpage>2277</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMe1705439</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">28581902</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Keerie</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tuck</surname> <given-names>C</given-names></string-name>, <string-name><surname>Milne</surname> <given-names>G</given-names></string-name>, <string-name><surname>Eldridge</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wright</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>SC</given-names></string-name>. <article-title>Data sharing in clinical trials - practical guidance on anonymising trial datasets</article-title>. <source>Trials</source>. <year>2018</year>;<volume>19</volume>(<issue>1</issue>):<fpage>25</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13063-017-2382-9</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">29321053</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Vines</surname> <given-names>TH</given-names></string-name>, <string-name><surname>Albert</surname> <given-names>AYK</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>RL</given-names></string-name>, <string-name><surname>D&#x00E9;barre</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bock</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Franklin</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Gilbert</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Moore</surname> <given-names>J-S</given-names></string-name>, <string-name><surname>Renaut</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rennison</surname> <given-names>DJ</given-names></string-name>. <article-title>The availability of research data declines rapidly with article age</article-title>. <source>Curr Biol</source>. <year>2014</year>;<volume>24</volume>(<issue>1</issue>):<fpage>94</fpage>&#x2013;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2013.11.014</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24361065</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Nosek</surname> <given-names>B.</given-names></string-name> <article-title>Estimating the reproducibility of psychological science</article-title>. <source>Science</source>. <year>2015</year>;<volume>349</volume>(<issue>6251</issue>):<fpage>aac4716</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aac4716</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">26315443</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Bernards</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>K</given-names></string-name>, <string-name><surname>Haff</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Bazyler</surname> <given-names>CD</given-names></string-name>. <article-title>Current Research and Statistical Practices in Sport Science and a Need for Change</article-title>. <source>Sports (Basel)</source>. <year>2017</year>;<volume>5</volume>(<issue>4</issue>). doi:<pub-id pub-id-type="doi">10.3390/sports5040087</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">29910447</pub-id>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Riemann</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Lininger</surname> <given-names>MR</given-names></string-name>. <article-title>Principles of Statistics: What the Sports Medicine Professional Needs to Know</article-title>. <source>Clin Sports Med</source>. <year>2018</year>;<volume>37</volume>(<issue>3</issue>):<fpage>375</fpage>&#x2013;<lpage>86</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.csm.2018.03.004</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">29903380</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Garc&#x00ED;a-Berthou</surname> <given-names>E</given-names></string-name>, <string-name><surname>Alcaraz</surname> <given-names>C.</given-names></string-name> <article-title>Incongruence between test statistics and P values in medical papers</article-title>. <source>BMC Med Res Methodol</source>. <year>2004</year>;<volume>4</volume>(<issue>1</issue>):<fpage>13</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2288-4-13</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">15169550</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Costello</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Bieuzen</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bleakley</surname> <given-names>CM</given-names></string-name>. <article-title>Where are all the female participants in Sports and Exercise Medicine research?</article-title> <source>Eur J Sport Sci</source>. <year>2014</year>;<volume>14</volume>(<issue>8</issue>):<fpage>847</fpage>&#x2013;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1080/17461391.2014.911354</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24766579</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="other"><collab>CONSORT</collab>. <source>Consort -Endorsers [Internet]</source>. <year>2021</year> [updated 2021 Mar 19; cited <date-in-citation content-type="access-date">2021 Mar 19</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.consort-statement.org/about-consort/endorsers1">http://www.consort-statement.org/about-consort/endorsers1</ext-link></mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Hirst</surname> <given-names>A</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>. <article-title>Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals</article-title>. <source>PLoS ONE</source>. <year>2012</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e35621</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0035621</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">22558178</pub-id>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Shamseer</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hopewell</surname> <given-names>S</given-names></string-name>, <string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Moher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>KF</given-names></string-name>. <article-title>Update on the endorsement of CONSORT by high impact factor journals: a survey of journal &#x201C;Instructions to Authors&#x201D; in 2014</article-title>. <source>Trials</source>. <year>2016</year>;<volume>17</volume>(<issue>1</issue>):<fpage>301</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13063-016-1408-z</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">27343072</pub-id>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>MacLeod</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Michie</surname> <given-names>S</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>I</given-names></string-name>, <string-name><surname>Dirnagl</surname> <given-names>U</given-names></string-name>, <string-name><surname>Chalmers</surname> <given-names>I</given-names></string-name>, <string-name><surname>Ioannidis</surname> <given-names>JPA</given-names></string-name>, <string-name><given-names>Salman</given-names> <surname>RA-S</surname></string-name>, <string-name><surname>Chan</surname> <given-names>A-W</given-names></string-name>, <string-name><surname>Glasziou</surname> <given-names>P.</given-names></string-name> <article-title>Biomedical research: increasing value, reducing waste</article-title>. <source>The Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9912</issue>):<fpage>101</fpage>&#x2013;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(13)62329-6</pub-id></mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname> <given-names>D.</given-names></string-name> <article-title>Reporting guidelines: doing better for readers</article-title>. <source>BMC Med</source>. <year>2018</year>;<volume>16</volume>(<issue>1</issue>):<fpage>233</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12916-018-1226-0</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">30545364</pub-id>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Keehan</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Gaffney</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Zucker</surname> <given-names>IH</given-names></string-name>. <article-title>CORP: Assessing author compliance with data presentation guidelines for manuscript figures</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2020</year>;<volume>318</volume>(<issue>5</issue>):<fpage>H1051</fpage>&#x2013;<lpage>H1058</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpheart.00071.2020</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32196356</pub-id>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Halffman</surname> <given-names>W</given-names></string-name>, <string-name><given-names>Horbach</given-names> <surname>Spjm</surname></string-name>. <article-title>What are innovations in peer review and editorial assessment for?</article-title> <source>Genome Biol</source>. <year>2020</year>;<volume>21</volume>(<issue>1</issue>):<fpage>87</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-020-02004-4</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">32362286</pub-id>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Checco</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bracciale</surname> <given-names>L</given-names></string-name>, <string-name><surname>Loreti</surname> <given-names>P</given-names></string-name>, <string-name><surname>Pinfield</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bianchi</surname> <given-names>G.</given-names></string-name> <article-title>AI-assisted peer review</article-title>. <source>Humanit Soc Sci Commun</source>. <year>2021</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>11</lpage>. En;en. doi:<pub-id pub-id-type="doi">10.1057/s41599-020-00703-8</pub-id></mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="website"><collab>BMC</collab>. <source>Advancing peer review at BMC [Internet]</source>. <year>2021</year> [updated 2021 Apr 8; cited <date-in-citation content-type="access-date">2021 Apr 8</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biomedcentral.com/about/advancing-peer-review">https://www.biomedcentral.com/about/advancing-peer-review</ext-link></mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><string-name><surname>Soboczenski</surname> <given-names>F</given-names></string-name>, <string-name><surname>Trikalinos</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Kuiper</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bias</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Wallace</surname> <given-names>BC</given-names></string-name>, <string-name><surname>Marshall</surname> <given-names>IJ</given-names></string-name>. <article-title>Machine learning to help researchers evaluate biases in clinical trials: a prospective, randomized user study</article-title>. <source>BMC Med Inform Decis Mak</source>. <year>2019</year>;<volume>19</volume>(<issue>1</issue>):<fpage>96</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12911-019-0814-z</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">31068178</pub-id>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Kilicoglu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Rosemblat</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hoang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wadhwa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Peng</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Mali&#x010D;ki</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schneider</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ter Riet</surname> <given-names>G.</given-names></string-name> <article-title>Toward assessing clinical trial publications for reporting transparency</article-title>. <source>J Biomed Inform</source>. <year>2021</year>;<volume>116103717</volume>. doi:<pub-id pub-id-type="doi">10.1016/j.jbi.2021.103717</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">33647518</pub-id>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Weissgerber</surname> <given-names>T</given-names></string-name>, <string-name><surname>Riedel</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kilicoglu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Labb&#x00E9;</surname> <given-names>C</given-names></string-name>, <string-name><surname>Eckmann</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ter Riet</surname> <given-names>G</given-names></string-name>, <string-name><surname>Byrne</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cabanac</surname> <given-names>G</given-names></string-name>, <string-name><surname>Capes-Davis</surname> <given-names>A</given-names></string-name>, <string-name><surname>Favier</surname> <given-names>B</given-names></string-name>, <string-name><surname>Saladi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Grabitz</surname> <given-names>P</given-names></string-name>, <string-name><surname>Bannach-Brown</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>R</given-names></string-name>, <string-name><surname>McCann</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bernard</surname> <given-names>R</given-names></string-name>, <string-name><surname>Bandrowski</surname> <given-names>A.</given-names></string-name> <article-title>Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?</article-title> <source>Nat Med</source>. <year>2021</year>;<volume>27</volume>(<issue>1</issue>):<fpage>6</fpage>&#x2013;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41591-020-01203-7</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">33432174</pub-id>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="other"><collab>European Comission</collab>. <source>Open science monitor [Internet]</source>. <year>2018</year> [updated 2018 Nov 7; cited <date-in-citation content-type="access-date">2021 Apr 10</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/open-science-monitor_en">https://ec.europa.eu/info/research-and-innovation/strategy/goals-research-and-innovation-policy/open-science/open-science-monitor_en</ext-link></mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="other"><collab>EU Trials Tracker. EU Trials Tracker &#x2014; Who&#x2019;s not sharing clinical trial results? [Internet]</collab>: <source>Evidence-Based Medicine Data Lab; University of Oxford</source>. <year>2021</year> [updated 2021 Apr 12; cited <date-in-citation content-type="access-date">2021 Apr 12</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://eu.trialstracker.net/">https://eu.trialstracker.net/</ext-link></mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="other"><string-name><surname>Altman</surname> <given-names>DG</given-names></string-name>. <article-title>WEBINAR: Doug Altman &#x2013; CONSORT Statement guidance for reporting randomised trials &#x007C; The EQUATOR Network [Internet]</article-title>: <source>EQUATOR</source>. <year>2013</year> [updated 2021 Apr 8; cited <date-in-citation content-type="access-date">2021 Apr 8</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.equator-network.org/2013/06/24/webinar-doug-altman-consort-statement-guidance-for-reporting-randomised-trials/">https://www.equator-network.org/2013/06/24/webinar-doug-altman-consort-statement-guidance-for-reporting-randomised-trials/</ext-link></mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="other"><collab>Society for Transparency, Openness, and Replication in Kinesiology</collab>. <source>Stork - Resources [Internet]</source>. <year>2021</year> [updated 2021 Apr 8; cited <date-in-citation content-type="access-date">2021 Apr 8</date-in-citation>]. Available from: <ext-link ext-link-type="uri" xlink:href="https://storkinesiology.org/resources/">https://storkinesiology.org/resources/</ext-link></mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Hoffmann</surname> <given-names>TC</given-names></string-name>, <string-name><surname>Erueti</surname> <given-names>C</given-names></string-name>, <string-name><surname>Glasziou</surname> <given-names>PP</given-names></string-name>. <article-title>Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials</article-title>. <source>BMJ</source>. <year>2013</year>;<volume>347f3755</volume>. doi:<pub-id pub-id-type="doi">10.1136/bmj.f3755</pub-id> Cited in: PubMed; PMID <pub-id pub-id-type="pmid">24021722</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>